Eupraxia Pharmaceuticals Inc. Common Stock Working Capital to Net Assets Ratio
Eupraxia Pharmaceuticals Inc. Common Stock working capital to net assets ratio. Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) has a Working Capital to Net Assets ratio of 99.0% as of September 2025. Working capital of $121.88 Million (current assets of $127.18 Million minus current liabilities of $5.30 Million) is measured against net assets of $123.06 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Eupraxia Pharmaceuticals Inc. Common Sto (EPRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Eupraxia Pharmaceuticals Inc. Common Stock (2017–2024)
Working capital to net assets ratio of Eupraxia Pharmaceuticals Inc. Common Stock from 2017 to 2024. This chart shows how Eupraxia Pharmaceuticals Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 99.0%, reflecting working capital of $121.88 Million against net assets of $123.06 Million USD. See defensive interval ratio of Eupraxia Pharmaceuticals Inc. Common Sto to measure how many days the company can operate on defensive assets alone.
Eupraxia Pharmaceuticals Inc. Common Stock Working Capital to Net Assets Ratio by Year (2017–2024)
Eupraxia Pharmaceuticals Inc. Common Stock working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Eupraxia Pharmaceuticals Inc. Common Stock from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see EPRX total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.4% | $31.33 Million | $31.84 Million | $34.44 Million | $3.10 Million | ▲ +50.3 pp |
| 2023 | 48.1% | $429.18K | $892.33K | $19.80 Million | $19.37 Million | ▼ -167.4 pp |
| 2022 | 215.5% | $21.03 Million | $9.76 Million | $25.17 Million | $4.14 Million | ▲ +67.3 pp |
| 2021 | 148.2% | $28.33 Million | $19.12 Million | $30.60 Million | $2.27 Million | ▲ +49.4 pp |
| 2020 | 98.8% | $-21.40 Million | $-21.66 Million | $1.14 Million | $22.54 Million | ▼ -0.6 pp |
| 2019 | 99.4% | $-18.03 Million | $-18.13 Million | $2.64 Million | $20.67 Million | ▼ -4.4 pp |
| 2018 | 103.8% | $-11.87 Million | $-11.44 Million | $2.47 Million | $14.34 Million | ▲ +11.9 pp |
| 2017 | 91.9% | $4.69 Million | $5.11 Million | $5.42 Million | $730.68K | — |